Partners Capital Investment Group, LLP Adaptive Biotechnologies Corp Transaction History

Partners Capital Investment Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.12 - $28.9 $1.53 Million - $4.36 Million	-150,935 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $1.15 Million - $1.68 Million	45,589 Added 43.28%	150,935 $4.24 Million
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $1.02 Million - $1.36 Million	34,000 Added 47.66%	105,346 $3.58 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $371,786 - $514,524	11,539 Added 19.29%	71,346 $2.92 Million
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $908,883 - $1.65 Million	24,393 Added 68.88%	59,807 $2.41 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $1.59 Million - $2.32 Million	35,414 New	35,414 $2.09 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Partners Capital Investment Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Partners Capital Investment Group, LLP with notifications on news.